3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 0 0 0 0 0 0999 V2000
-3.8276 0.9200 -0.2053 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.4331 -1.3084 0.2598 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5078 0.2380 -0.0399 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7802 -0.3369 0.0739 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2232 0.9767 0.2288 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7011 -1.3630 -0.1378 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5870 1.2641 0.1720 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0648 -1.0755 -0.1946 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9658 0.5454 -0.1012 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6417 -0.6368 0.1343 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6367 0.2595 -0.0483 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0509 -0.1724 0.0276 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2399 0.6892 -0.1695 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5455 1.8043 0.4161 H 0 0 0 0 0 0 0 0 0 0 0 0
1.3748 -2.3928 -0.2615 H 0 0 0 0 0 0 0 0 0 0 0 0
2.9209 2.2905 0.3002 H 0 0 0 0 0 0 0 0 0 0 0 0
3.7727 -1.8837 -0.3585 H 0 0 0 0 0 0 0 0 0 0 0 0
5.4895 -0.1531 -0.7627 H 0 0 0 0 0 0 0 0 0 0 0 0
5.1412 1.5521 -0.4958 H 0 0 0 0 0 0 0 0 0 0 0 0
5.4061 0.4789 0.8986 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.8917 -1.6770 0.3327 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.4535 1.3038 -0.2747 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.5255 -0.0313 -0.9418 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.7447 1.6379 -0.3704 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.5405 0.3341 0.8209 H 0 0 0 0 0 0 0 0 0 0 0 0
1 12 1 0 0 0 0
1 13 1 0 0 0 0
2 12 2 0 0 0 0
3 7 2 0 0 0 0
3 8 1 0 0 0 0
3 9 1 0 0 0 0
4 5 2 0 0 0 0
4 6 1 0 0 0 0
4 10 1 0 0 0 0
5 7 1 0 0 0 0
5 14 1 0 0 0 0
6 8 2 0 0 0 0
6 15 1 0 0 0 0
7 16 1 0 0 0 0
8 17 1 0 0 0 0
9 18 1 0 0 0 0
9 19 1 0 0 0 0
9 20 1 0 0 0 0
10 11 2 0 0 0 0
10 21 1 0 0 0 0
11 12 1 0 0 0 0
11 22 1 0 0 0 0
13 23 1 0 0 0 0
13 24 1 0 0 0 0
13 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
methyl (E)-3-(4-methylphenyl)prop-2-enoate
4.2 InChl
InChI=1S/C11H12O2/c1-9-3-5-10(6-4-9)7-8-11(12)13-2/h3-8H,1-2H3/b8-7+
4.3 InChlKey
WLJBRXRCJNSDHT-BQYQJAHWSA-N
4.4 Canonical SMILES
CC1=CC=C(C=C1)C=CC(=O)OC
4.5 lsomeric SMILES
CC1=CC=C(C=C1)/C=C/C(=O)OC
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病